Four people have now died in a case allegedly tied to
pharmaceutical products manufactured by Cedar Park-based Specialty
Compounding.
Last week, the Federal Food and Drug Administration announced a national recall of all of the company's products after reports surfaced out of a Corpus Christi hospital that 17 patients had become infected with bacterial infections after receiving injections of one of the company's products.
Four of the patients have now died, but a
spokesman for the Texas Department of State Health Services said that
the cause of the deaths is still under investigation, and at this time
no link has been established between the medications and the deaths.
Corpus Christi attorney Thomas J. Henry’s website says that 19 people have retained Henry’s firm claiming injuries tied to products involved in the recall, including the families of the four patients who allegedly died after developing bacterial infections linked to the calcium gluconate treatments.
According to the Corpus Christi Caller-Times, the Corpus Christi Medical Center says that it will be notifying 114 patients who received a treatment that may be linked to the Specialty Compounding recall.
Officials in Texas are working with the Centers for Disease Control and Prevention to analyze samples of the bacteria taken from infected patients, but results of the tests are not expected until next week.
Texas health officials told the CDC that patients who received calcium gluconate manufactured by Specialty Compounding developed bloodstream infections, and the CDC says that an intact sample of the calcium gluconate made by the firm showed growth of bacteria of the specific bacteria found in the infected patients.
The company has voluntarily recalled all the products it has manufactured and distributed since May 9 and a company spokesperson told Hill Country News though a written statement that the company is cooperating with authorities, and that, "Our top priority is patient safety and ensuring that all recalled products are promptly returned to the pharmacy."
The statement goes on to say, "The source of the bacteria has not been identified. Results from laboratory testing on samples of our calcium gluconate infusion product, which was distributed to hospitals only within Texas, are expected later this week and we will keep the public apprised of the process."
http://www.hillcountrynews.com/news/article_08080730-1019-11e3-aeff-0019bb2963f4.html
Last week, the Federal Food and Drug Administration announced a national recall of all of the company's products after reports surfaced out of a Corpus Christi hospital that 17 patients had become infected with bacterial infections after receiving injections of one of the company's products.
Corpus Christi attorney Thomas J. Henry’s website says that 19 people have retained Henry’s firm claiming injuries tied to products involved in the recall, including the families of the four patients who allegedly died after developing bacterial infections linked to the calcium gluconate treatments.
According to the Corpus Christi Caller-Times, the Corpus Christi Medical Center says that it will be notifying 114 patients who received a treatment that may be linked to the Specialty Compounding recall.
Officials in Texas are working with the Centers for Disease Control and Prevention to analyze samples of the bacteria taken from infected patients, but results of the tests are not expected until next week.
Texas health officials told the CDC that patients who received calcium gluconate manufactured by Specialty Compounding developed bloodstream infections, and the CDC says that an intact sample of the calcium gluconate made by the firm showed growth of bacteria of the specific bacteria found in the infected patients.
The company has voluntarily recalled all the products it has manufactured and distributed since May 9 and a company spokesperson told Hill Country News though a written statement that the company is cooperating with authorities, and that, "Our top priority is patient safety and ensuring that all recalled products are promptly returned to the pharmacy."
The statement goes on to say, "The source of the bacteria has not been identified. Results from laboratory testing on samples of our calcium gluconate infusion product, which was distributed to hospitals only within Texas, are expected later this week and we will keep the public apprised of the process."
http://www.hillcountrynews.com/news/article_08080730-1019-11e3-aeff-0019bb2963f4.html
No comments:
Post a Comment